A common symptom in advanced cancers is the build-up of fluid in the chest, known as a malignant pleural effusion (MPE), which causes distressing shortness of breath and chest pain. Half of patients with metastatic disease will develop MPE.
SymPhysis Medical are developing a catheter-based technology called RelEase that will be a significantly more effective and patient-centric solution for managing MPE in the home compared to current solutions.
SymPhysis Medical are developing a catheter-based technology called RelEase that will be a significantly more effective and patient-centric solution for managing MPE in the home compared to current solutions.
Location: Ireland
Employees: 1-10
Total raised: $6.1M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 23.07.2023 | Irrus Inve... | irrusinves... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 08.10.2024 | - | $2.41M | - |
| 21.12.2023 | - | $1.64M | - |
| 25.04.2022 | - | $2.04M | - |
Mentions in press and media 12
| Date | Title | Description |
| 13.03.2026 | SparksWealth acquires Aidan Moore Financial Brokers | Financial planning business SparksWealth has acquired the south Dublin-based financial advisory practice Aidan Moore Financial Brokers. Terms of the deal were not disclosed. The acquisition represents another step in the continued growth of... |
| 12.03.2026 | SymPhysis Medical opens EIIS funding round for pleural effusion drainage system | Galway-based medtech SymPhysis Medical has opened an EIIS funding round to support the development of its pleural effusion drainage system. Pleural effusion is associated with severe breathlessness and repeated hospital visits, particularly... |
| 20.06.2025 | SymPhysis Medical seeking Spark investor interest | Irish MedTech, SymPhysis Medical, is seeking Spark investors to back its pioneering new medical device, founded through the BioInnovate Ireland Fellowship Programme at the University of Galway. Already at an advanced stage of development, r... |
| 10.10.2024 | SymPhysis Medical: Pioneering Independence for Cancer Patients with Innovative Drainage Device | In the world of medical technology, innovation often emerges from necessity. SymPhysis Medical, a Galway-based company, embodies this principle. With a recent funding boost of $2.4 million, the company is on a mission to transform the lives... |
| 08.10.2024 | Large deals are at the forefront of M&A activity in 2024 | Large deals have been at the forefront of M&A activity in 2024, according to research on completed deals from WTW’s Quarterly Deal Performance Monitor (QDPM). The trend reflects a growing confidence among dealmakers despite geopolitical... |
| 08.10.2024 | Report: SymPhysis Medical raises $2.4M to support cancer device | The Releaze drainage system. [Image from the SymPhysis website]SymPhysis Medical raised $2.4 million (€2.2 million) to support its Releaze drainage system for cancer patients, RTE reports. According to the report, the funding follows a $1.6... |
| 07.10.2024 | SymPhysis Medical raises €2.2m to launch device in the US | Galway MedTech company SymPhysis Medical has received €2.2m in funding as it prepares for regulatory clearance in the US. The funding consists of follow-on investments from Irrus Investments, the MedTech Syndicate and Boole Investments alon... |
| 21.12.2023 | Galway MedTech SymPhysis Medical raises €1.5m for expansion | Galway-based MedTech company SymPhysis Medical has raised €1.5m in a seed-plus funding round. The firm is developing a draining device called 'releaze' for people with fluid in their chest, which significantly compromises the quality of lif... |
| 25.04.2022 | Galway-based healthtech startup SymPhysis Medical picks up €1.9 million for its patient-centred solutions | Driven by a commitment to provide more independence and a better quality of life to patients, SymPhysis Medical has just picked up €1.9 million for its healthtech that is patient-centric. Funding for the Irish startup was led by HBAN (Halo ... |
| 25.04.2022 | Angel investors back novel cancer treatment | A novel treatment for cancer patients from SymPhysis Medical has attracted seed funding of €1.9m, with angel investors contributing €925,000. SymPhysis Medical in Galway is developing a device that treats fluid in the chest, a condition exp... |
Show more